NOVEMBER - 20186According to WHO, Cancer is the second most common cause of death globally, with an estimated 9.6 million deaths in 2018. However, with advancements in early detection and treatment technique in the field of oncology, institutions are able to push cancer incidence and mortality rate into a declining phase today.Oncology experts and clinical leaders understand that emerging technologies offer new options for detection and recovery from cancer. The past decade witnessed a huge growth in oncology treatment options with over 63 new approved cancer agents for 78 cancer indications. A significant milestone is the approval of precision oncology medicine--a directing therapy based on genomic biomarkers and independent of cancer type. Precision oncology has demonstrated promising treatment outcomes and it can significantly impact the treatment of cancer. Meanwhile, Immuno-oncology therapies have also proven to be promising and they have been used to treat a wide range of cancers.With the emergence of next-generation therapies and advanced treatment technologies, patients are gaining access to more treatment options, causing a complete shift in the treatment of cancer. Staying on top of the innovations in this field can help cancer care centers establish or maintain their status as leaders in cancer care. In tandem with the evolution of technologies adopted in oncology, Medtech Outlook presents to you its special edition on oncology solutions. In this edition, we are featuring some of the most promising oncology solution providers who offer exceptional technology solutions and services in the industry. We hope the insights from industry thought-leaders and innovative technologies from the leading vendors will assist you in improving cancer treatment.Copyright © 2018 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 1 - 2018ONCOLOGY SPECIALVOLUME 01 - 08Contact UsPhone:510 230 0396 Fax:510-894-8405Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comManaging EditorAlex D'souzaEditorial StaffSalesJoe Philip Laura PintoMatthew JacobMerlin WatsonSarah FernandesVinutha DayanandVisualizerJeevan JyothiEric Thomaseric@medicaltechoutlook.com510 565 7623Alex D'souzaManaging Editoreditor@Medicaltechoutlook.comRedefining Cancer Care*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditorialPublished by ValleyMedia Inc. To subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com
< Page 5 | Page 7 >